MicroRNA-663 antagonizes apoptosis antagonizing transcription factor to induce apoptosis in epithelial cells.


Journal

Apoptosis : an international journal on programmed cell death
ISSN: 1573-675X
Titre abrégé: Apoptosis
Pays: Netherlands
ID NLM: 9712129

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 6 1 2019
medline: 21 4 2020
entrez: 6 1 2019
Statut: ppublish

Résumé

MicroRNAs are small functional RNAs that modulate various biological processes in cells by interfering with gene translation. We have previously demonstrated that certain miRNAs play a crucial role in the innate immune responses of human oral epithelial cells to Porphyromonas gingivalis. While addressing the mechanisms of P. gingivalis induced apoptosis in these cells, we discovered that certain miRNAs are upregulated upon stimulation with live bacteria. These upregulated miRNAs include hsa-miR-584, hsa-miR-572, hsa-miR-210, hsa-miR-492, hsa-miR-623 and hsa-miR-663. Further analysis revealed an unexpected role for hsa-miR-663 (miR-663). To further evaluate miR-663 function, we overexpressed miR-663 in epithelial cells which resulted in cellular apoptosis. The bioinformatics analysis of the miR-663 target prediction, revealed a strong binding affinity to a 3' UTR region of Apoptosis Antagonizing Transcription Factor (AATF) mRNA. To demonstrate the binding of miR-663 to AATF mRNA, the putative miR-663 target site within the 3'-UTR region of AATF was cloned in luciferase vector and transfected to HEK293T cells. Luminescence data showed the downregulation of luciferase activity in cells that had the full length target region of the putative binding site, confirming that AATF is one of the targets for miR-663. This prompted us to further evaluate its role in a cancer cell line (MCF-7) to determine miR-663s' apoptotic function. The overexpression of miR-663 led to a significant increase in apoptosis of MCF-7 cells. Taken together, miR-663 may function as an 'apoptomiR' by inhibiting the anti-apoptotic gene AATF to induce apoptosis. These findings could have therapeutic implications for epithelial cell targeting in cancer therapy.

Identifiants

pubmed: 30610504
doi: 10.1007/s10495-018-01513-9
pii: 10.1007/s10495-018-01513-9
doi:

Substances chimiques

AATF protein, human 0
Apoptosis Regulatory Proteins 0
MIRN663 microRNA, human 0
MicroRNAs 0
Repressor Proteins 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-118

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE024160
Pays : United States

Références

Benakanakere M, Kinane DF (2012) Innate cellular responses to the periodontal biofilm. Front Oral Biol 15:41–55. https://doi.org/10.1159/000329670
doi: 10.1159/000329670 pubmed: 22142956
Kinane DF, Galicia JC, Gorr SU, Stathopoulou PG, Benakanakere M (2008) P. gingivalis interactions with epithelial cells. Front Biosci 13:966–984
doi: 10.2741/2736 pubmed: 17981604
Kinane JA, Benakanakere MR, Zhao J, Hosur KB, Kinane DF (2012) Porphyromonas gingivalis influences actin degradation within epithelial cells during invasion and apoptosis. Cell Microbiol 14(7):1085–1096. https://doi.org/10.1111/j.1462-5822.2012.01780.x
doi: 10.1111/j.1462-5822.2012.01780.x pubmed: 22381126
Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF (2009) The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol 24(1):11–17. https://doi.org/10.1111/j.1399-302X.2008.00467.x
doi: 10.1111/j.1399-302X.2008.00467.x pubmed: 19121064 pmcid: 2717190
Stathopoulou PG, Galicia JC, Benakanakere MR, Garcia CA, Potempa J, Kinane DF (2009) Porphyromonas gingivalis induce apoptosis in human gingival epithelial cells through a gingipain-dependent mechanism. BMC Microbiol 9:107. https://doi.org/10.1186/1471-2180-9-107
doi: 10.1186/1471-2180-9-107 pubmed: 19473524 pmcid: 2692854
Kiraz Y, Adan A, Kartal Yandim M, Baran Y (2016) Major apoptotic mechanisms and genes involved in apoptosis. Tumour Biol 37(7):8471–8486. https://doi.org/10.1007/s13277-016-5035-9
doi: 10.1007/s13277-016-5035-9 pubmed: 27059734
Koulouri O, Lappin DF, Radvar M, Kinane DF (1999) Cell division, synthetic capacity and apoptosis in periodontal lesions analysed by in situ hybridisation and immunohistochemistry. J Clin Periodontol 26(8):552–559
doi: 10.1034/j.1600-051X.1999.260810.x pubmed: 10450817
Tonetti MS, Cortellini D, Lang NP (1998) In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingiva. Infect Immun 66(11):5190–5195
pubmed: 9784521 pmcid: 108647
Brozovic S, Sahoo R, Barve S, Shiba H, Uriarte S, Blumberg RS, Kinane DF (2006) Porphyromonas gingivalis enhances FasL expression via up-regulation of NFkappaB-mediated gene transcription and induces apoptotic cell death in human gingival epithelial cells. Microbiology 152(Pt 3):797–806. https://doi.org/10.1099/mic.0.28472-0
doi: 10.1099/mic.0.28472-0 pubmed: 16514159
Galicia JC, Benakanakere MR, Stathopoulou PG, Kinane DF (2009) Neutrophils rescue gingival epithelial cells from bacterial-induced apoptosis. J Leukoc Biol 86(1):181–186. https://doi.org/10.1189/jlb.0109003
doi: 10.1189/jlb.0109003 pubmed: 19389800 pmcid: 2704621
Imatani T, Kato T, Okuda K, Yamashita Y (2004) Histatin 5 inhibits apoptosis in human gingival fibroblasts induced by Porphyromonas gingivalis cell-surface polysaccharide. Eur J Med Res 9(11):528–532
pubmed: 15649864
Urnowey S, Ansai T, Bitko V, Nakayama K, Takehara T, Barik S (2006) Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: potential role of bacterial proteases in host signalling. BMC Microbiol 6:26
doi: 10.1186/1471-2180-6-26 pubmed: 16524480 pmcid: 1431544
Kobayashi-Sakamoto M, Hirose K, Nishikata M, Isogai E, Chiba I (2006) Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases. FEMS Microbiol Lett 264(2):238–245
doi: 10.1111/j.1574-6968.2006.00458.x pubmed: 16981905
Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E (2007) Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol Lett 272(1):106–113
doi: 10.1111/j.1574-6968.2007.00736.x
Sheets SM, Potempa J, Travis J, Casiano CA, Fletcher HM (2005) Gingipains from Porphyromonas gingivalis W83 induce cell adhesion molecule cleavage and apoptosis in endothelial cells. Infect Immun 73(3):1543–1552
doi: 10.1128/IAI.73.3.1543-1552.2005 pubmed: 15731052 pmcid: 1064927
Sheets SM, Potempa J, Travis J, Fletcher HM, Casiano CA (2006) Gingipains from Porphyromonas gingivalis W83 synergistically disrupt endothelial cell adhesion and can induce caspase-independent apoptosis. Infect Immun 74(10):5667–5678
doi: 10.1128/IAI.01140-05 pubmed: 16988242 pmcid: 1594922
Geatch DR, Harris JI, Heasman PA, Taylor JJ (1999) In vitro studies of lymphocyte apoptosis induced by the periodontal pathogen Porphyromonas gingivalis. J Periodontal Res 34(2):70–78
doi: 10.1111/j.1600-0765.1999.tb02225.x pubmed: 10207835
Vecchione A, Croce CM (2010) Apoptomirs: small molecules have gained the license to kill. Endocr Relat Cancer 17(1):F37–F50. https://doi.org/10.1677/erc-09-0163
doi: 10.1677/erc-09-0163 pubmed: 19815577
Burin SM, Berzoti-Coelho MG, Cominal JG, Ambrosio L, Torqueti MR, Sampaio SV, de Castro FA (2016) The L-amino acid oxidase from Calloselasma rhodostoma snake venom modulates apoptomiRs expression in Bcr-Abl-positive cell lines. Toxicon 120:9–14. https://doi.org/10.1016/j.toxicon.2016.07.008
doi: 10.1016/j.toxicon.2016.07.008 pubmed: 27421670
Sharma S, Patnaik PK, Aronov S, Kulshreshtha R (2016) ApoptomiRs of breast cancer: basics to clinics. Front Genet 7:175. https://doi.org/10.3389/fgene.2016.00175
doi: 10.3389/fgene.2016.00175 pubmed: 27746811 pmcid: 5041507
Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA (2011) Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33(4):504–512. https://doi.org/10.1002/hed.21475
doi: 10.1002/hed.21475 pubmed: 20652977 pmcid: 3080748
Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB, Kinane DF (2009) Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 284(34):23107–23115. https://doi.org/10.1074/jbc.M109.013862
doi: 10.1074/jbc.M109.013862 pubmed: 19509287 pmcid: 2755716
Chen Y, Fu LL, Wen X, Liu B, Huang J, Wang JH, Wei YQ (2014) Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy. Apoptosis 19(8):1177–1189. https://doi.org/10.1007/s10495-014-0999-7
doi: 10.1007/s10495-014-0999-7 pubmed: 24850099
Nakano H, Miyazawa T, Kinoshita K, Yamada Y, Yoshida T (2010) Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int J Cancer 127(5):1072–1080. https://doi.org/10.1002/ijc.25143
doi: 10.1002/ijc.25143 pubmed: 20039318
Chen Q, Xu J, Li L, Li H, Mao S, Zhang F, Zen K, Zhang CY, Zhang Q (2014) MicroRNA-23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis 5:e1132. https://doi.org/10.1038/cddis.2014.92
doi: 10.1038/cddis.2014.92 pubmed: 24651435 pmcid: 3973202
Lin YC, Lin JF, Tsai TF, Chou KY, Chen HE, Hwang TI (2016) Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. Asian J Surg. https://doi.org/10.1016/j.asjsur.2016.07.001
doi: 10.1016/j.asjsur.2016.07.001 pubmed: 28010955
Lin Z, Zhao J, Wang X, Zhu X, Gong L (2016) Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer. Oncol Rep 36(4):2101–2107. https://doi.org/10.3892/or.2016.5012
doi: 10.3892/or.2016.5012 pubmed: 27513319
Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102(39):13944–13949. https://doi.org/10.1073/pnas.0506654102
doi: 10.1073/pnas.0506654102 pubmed: 16166262 pmcid: 1236577
Garofalo M, Quintavalle C, Di Leva G, Zanca C, Romano G, Taccioli C, Liu CG, Croce CM, Condorelli G (2008) MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene 27(27):3845–3855. https://doi.org/10.1038/onc.2008.6
doi: 10.1038/onc.2008.6 pubmed: 18246122
Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5):745–752. https://doi.org/10.1016/j.molcel.2007.05.010
doi: 10.1016/j.molcel.2007.05.010 pubmed: 17540599 pmcid: 1939978
He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ (2007) A microRNA component of the p53 tumour suppressor network. Nature 447(7148):1130–1134. https://doi.org/10.1038/nature05939
doi: 10.1038/nature05939 pubmed: 17554337 pmcid: 4590999
Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A (2008) E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13(3):272–286. https://doi.org/10.1016/j.ccr.2008.02.013
doi: 10.1016/j.ccr.2008.02.013 pubmed: 18328430
Zhao J, Benakanakere MR, Hosur KB, Galicia JC, Martin M, Kinane DF (2010) Mammalian target of rapamycin (mTOR) regulates TLR3 induced cytokines in human oral keratinocytes. Mol Immunol 48(1–3):294–304. https://doi.org/10.1016/j.molimm.2010.07.014
doi: 10.1016/j.molimm.2010.07.014 pubmed: 20728939 pmcid: 4372152
Benakanakere M, Abdolhosseini M, Hosur K, Finoti LS, Kinane DF (2015) TLR2 promoter hypermethylation creates innate immune dysbiosis. J Dent Res 94(1):183–191. https://doi.org/10.1177/0022034514557545
doi: 10.1177/0022034514557545 pubmed: 25389002 pmcid: 4270813
Benakanakere MR, Zhao J, Galicia JC, Martin M, Kinane DF (2010) Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes. PLoS ONE 5(7):e11512. https://doi.org/10.1371/journal.pone.0011512
doi: 10.1371/journal.pone.0011512 pubmed: 20634980 pmcid: 2901390
Eskan MA, Benakanakere MR, Rose BG, Zhang P, Zhao J, Stathopoulou P, Fujioka D, Kinane DF (2008) Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect Immun 76(5):2080–2089. https://doi.org/10.1128/IAI.01428-07
doi: 10.1128/IAI.01428-07 pubmed: 18332211 pmcid: 2346720
Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF (2010) Epithelial cell pro-inflammatory cytokine response differs across dental plaque bacterial species. J Clin Periodontol 37(1):24–29. https://doi.org/10.1111/j.1600-051X.2009.01505.x
doi: 10.1111/j.1600-051X.2009.01505.x pubmed: 20096064 pmcid: 2900159
Eskan MA, Rose BG, Benakanakere MR, Zeng Q, Fujioka D, Martin MH, Lee MJ, Kinane DF (2008) TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. Eur J Immunol 38(4):1138–1147. https://doi.org/10.1002/eji.200737898
doi: 10.1002/eji.200737898 pubmed: 18395849 pmcid: 2738989
Eskan MA, Rose BG, Benakanakere MR, Lee MJ, Kinane DF (2008) Sphingosine 1-phosphate 1 and TLR4 mediate IFN-beta expression in human gingival epithelial cells. J Immunol 180(3):1818–1825
doi: 10.4049/jimmunol.180.3.1818 pubmed: 18209079
Kinane DF, Shiba H, Stathopoulou PG, Zhao H, Lappin DF, Singh A, Eskan MA, Beckers S, Waigel S, Alpert B, Knudsen TB (2006) Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun 7(3):190–200. https://doi.org/10.1038/sj.gene.6364282
doi: 10.1038/sj.gene.6364282 pubmed: 16437123
Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95(25):14863–14868
doi: 10.1073/pnas.95.25.14863 pubmed: 9843981 pmcid: 24541
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262S1046-2023(01)91262-9
doi: 10.1006/meth.2001.1262S1046-2023(01)91262-9 pubmed: 11846609
Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y, Yun JP (2012) MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31(41):4421–4433. https://doi.org/10.1038/onc.2011.629
doi: 10.1038/onc.2011.629 pubmed: 22249270
Zang W, Wang Y, Wang T, Du Y, Chen X, Li M, Zhao G (2015) miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer. Mol Cancer 14:37. https://doi.org/10.1186/s12943-015-0315-3
doi: 10.1186/s12943-015-0315-3 pubmed: 25744894 pmcid: 4332743
Zhang Y, Xu X, Zhang M, Wang X, Bai X, Li H, Kan L, Zhou Y, Niu H, He P (2016) MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD. BMC Cancer 16:315. https://doi.org/10.1186/s12885-016-2350-x
doi: 10.1186/s12885-016-2350-x pubmed: 27184257 pmcid: 4869303
Liu J, Drescher KM, Chen X-M (2009) MicroRNAs and epithelial immunity. Int Rev Immunol 28(3–4):139–154. https://doi.org/10.1080/08830180902943058 doi
doi: 10.1080/08830180902943058 pubmed: 19811319 pmcid: 2764336
Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39(Database issue):D152–D157. https://doi.org/10.1093/nar/gkq1027
doi: 10.1093/nar/gkq1027
Munker R, Calin GA (2011) MicroRNA profiling in cancer. Clin Sci 121(4):141–158. https://doi.org/10.1042/CS20110005
doi: 10.1042/CS20110005
Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA 109(26):E1695–E1704. https://doi.org/10.1073/pnas.1201516109
doi: 10.1073/pnas.1201516109 pubmed: 22685206 pmcid: 3387084
Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269. https://doi.org/10.1038/nrc1840
doi: 10.1038/nrc1840 pubmed: 16557279
Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467(7311):86–90. https://doi.org/10.1038/nature09284
doi: 10.1038/nature09284 pubmed: 20693987
Cheng CJ, Bahal R, Babar IA, Pincus Z, Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM, Saltzman WM, Slack FJ (2015) MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature 518(7537):107–110. https://doi.org/10.1038/nature13905
doi: 10.1038/nature13905 pubmed: 25409146
Jian P, Li ZW, Fang TY, Jian W, Zhuan Z, Mei LX, Yan WS, Jian N (2011) Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol 4:20. https://doi.org/10.1186/1756-8722-4-20
doi: 10.1186/1756-8722-4-20 pubmed: 21518431 pmcid: 3094392
Ni CW, Qiu H, Jo H (2011) MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 300(5):H1762–H1769. https://doi.org/10.1152/ajpheart.00829.2010
doi: 10.1152/ajpheart.00829.2010 pubmed: 21378144 pmcid: 3094086
Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L (2013) The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). J Biol Chem 288(16):10973–10985. https://doi.org/10.1074/jbc.M112.434340
doi: 10.1074/jbc.M112.434340 pubmed: 23436656 pmcid: 3630848
Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z, Ran Y (2010) Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24(1):105–112
pubmed: 20514450
Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM (2010) Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 31(9):1561–1566. https://doi.org/10.1093/carcin/bgq143
doi: 10.1093/carcin/bgq143 pubmed: 20622002 pmcid: 4647642
Pisani C, Onori A, Gabanella F, Delle Monache F, Borreca A, Ammassari-Teule M, Fanciulli M, Di Certo MG, Passananti C, Corbi N (2016) eEF1Bgamma binds the Che-1 and TP53 gene promoters and their transcripts. J Exp Clin Cancer Res 35(1):146. https://doi.org/10.1186/s13046-016-0424-x
doi: 10.1186/s13046-016-0424-x pubmed: 27639846 pmcid: 5027090
Bruno T, Iezzi S, Fanciulli M (2016) Che-1/AATF: a critical cofactor for both wild-type- and mutant-p53 proteins. Front Oncol 6:34. https://doi.org/10.3389/fonc.2016.00034
doi: 10.3389/fonc.2016.00034 pubmed: 26913241 pmcid: 4753824
Passananti C, Fanciulli M (2007) The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response. Cell Div 2:21. https://doi.org/10.1186/1747-1028-2-21
doi: 10.1186/1747-1028-2-21 pubmed: 17634135 pmcid: 1948887
Jackson JG, Lozano G (2012) Che-ating death: CHE1/AATF protects from p53-mediated apoptosis. EMBO J 31(20):3951–3953. https://doi.org/10.1038/emboj.2012.258
doi: 10.1038/emboj.2012.258 pubmed: 22960635 pmcid: 3474930
Iezzi S, Fanciulli M (2015) Discovering Che-1/AATF: a new attractive target for cancer therapy. Front Genet 6:141. https://doi.org/10.3389/fgene.2015.00141
doi: 10.3389/fgene.2015.00141 pubmed: 25914721 pmcid: 4392318
Folgiero V, Sorino C, Locatelli F, Fanciulli M (2018) A new baby in the c-Myc-directed transcriptional machinery: Che-1/AATF. Cell Cycle 17(11):1286–1290. https://doi.org/10.1080/15384101.2018.1480227
doi: 10.1080/15384101.2018.1480227 pubmed: 29943642 pmcid: 6110579
Folgiero V, Sorino C, Pallocca M, De Nicola F, Goeman F, Bertaina V, Strocchio L, Romania P, Pitisci A, Iezzi S, Catena V, Bruno T, Strimpakos G, Passananti C, Mattei E, Blandino G, Locatelli F, Fanciulli M (2018) Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia. EMBO Rep. https://doi.org/10.15252/embr.201744871
doi: 10.15252/embr.201744871 pubmed: 29367285 pmcid: 5835840
Di Certo MG, Corbi N, Bruno T, Iezzi S, De Nicola F, Desantis A, Ciotti MT, Mattei E, Floridi A, Fanciulli M, Passananti C (2007) NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci 120(Pt 11):1852–1858. https://doi.org/10.1242/jcs.03454
doi: 10.1242/jcs.03454 pubmed: 17488777
Guo Q, Xie J (2004) AATF inhibits aberrant production of amyloid beta peptide 1–42 by interacting directly with Par-4. J Biol Chem 279(6):4596–4603. https://doi.org/10.1074/jbc.M309811200
doi: 10.1074/jbc.M309811200 pubmed: 14627703
Xie J, Guo Q (2004) AATF protects neural cells against oxidative damage induced by amyloid beta-peptide. Neurobiol Dis 16(1):150–157. https://doi.org/10.1016/j.nbd.2004.02.003
doi: 10.1016/j.nbd.2004.02.003 pubmed: 15207272
Ferraris SE, Isoniemi K, Torvaldson E, Anckar J, Westermarck J, Eriksson JE (2012) Nucleolar AATF regulates c-Jun-mediated apoptosis. Mol Biol Cell 23(21):4323–4332. https://doi.org/10.1091/mbc.E12-05-0419
doi: 10.1091/mbc.E12-05-0419 pubmed: 22933572 pmcid: 3484108
Bruno T, Valerio M, Casadei L, De Nicola F, Goeman F, Pallocca M, Catena V, Iezzi S, Sorino C, Desantis A, Manetti C, Blandino G, Floridi A, Fanciulli M (2017) Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1alpha stabilization. J Exp Clin Cancer Res 36(1):32. https://doi.org/10.1186/s13046-017-0497-1
doi: 10.1186/s13046-017-0497-1 pubmed: 28214471 pmcid: 5316229
Bruno T, De Angelis R, De Nicola F, Barbato C, Di Padova M, Corbi N, Libri V, Benassi B, Mattei E, Chersi A, Soddu S, Floridi A, Passananti C, Fanciulli M (2002) Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb. Cancer Cell 2(5):387–399
doi: 10.1016/S1535-6108(02)00182-4 pubmed: 12450794
Bruno T, De Nicola F, Iezzi S, Lecis D, D’Angelo C, Di Padova M, Corbi N, Dimiziani L, Zannini L, Jekimovs C, Scarsella M, Porrello A, Chersi A, Crescenzi M, Leonetti C, Khanna KK, Soddu S, Floridi A, Passananti C, Delia D, Fanciulli M (2006) Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint. Cancer Cell 10(6):473–486. https://doi.org/10.1016/j.ccr.2006.10.012
doi: 10.1016/j.ccr.2006.10.012 pubmed: 17157788
Ishigaki S, Fonseca SG, Oslowski CM, Jurczyk A, Shearstone JR, Zhu LJ, Permutt MA, Greiner DL, Bortell R, Urano F (2010) AATF mediates an antiapoptotic effect of the unfolded protein response through transcriptional regulation of AKT1. Cell Death Differ 17(5):774–786. https://doi.org/10.1038/cdd.2009.175
doi: 10.1038/cdd.2009.175 pubmed: 19911006
Kumar DP, Santhekadur PK, Seneshaw M, Mirshahi F, Tuculescu CU, Sanyal AJ (2018) A novel regulatory role of apoptosis antagonizing transcription factor in the pathogenesis of NAFLD and HCC. Hepatology. https://doi.org/10.1002/hep.30346
doi: 10.1002/hep.30346 pubmed: 29655183
Welcker D, Jain M, Khurshid S, Jokic M, Hohne M, Schmitt A, Frommolt P, Niessen CM, Spiro J, Persigehl T, Wittersheim M, Buttner R, Fanciulli M, Schermer B, Reinhardt HC, Benzing T, Hopker K (2018) AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer. Oncogene 37(11):1503–1518. https://doi.org/10.1038/s41388-017-0054-6
doi: 10.1038/s41388-017-0054-6 pubmed: 29321668
Sharma S, Kaul D, Arora M, Malik D (2015) Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells. Cell Biol Int 39(3):326–333. https://doi.org/10.1002/cbin.10379
doi: 10.1002/cbin.10379 pubmed: 25231211
Sharma M (2013) Apoptosis-antagonizing transcription factor (AATF) gene silencing: role in induction of apoptosis and down-regulation of estrogen receptor in breast cancer cells. Biotechnol Lett 35(10):1561–1570. https://doi.org/10.1007/s10529-013-1257-8
doi: 10.1007/s10529-013-1257-8 pubmed: 23801113

Auteurs

M R Benakanakere (MR)

Department of Periodontics, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Philadelphia, PA, 19104, USA. bmanju@upenn.edu.

J Zhao (J)

Department of Pathology, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Department of Pathology, Wayne State University School of Medicine, 541 East Canfield Ave., Scott Hall 9215, Detroit, MI, 48201, USA.

L Finoti (L)

Department of Periodontics, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Philadelphia, PA, 19104, USA.

R Schattner (R)

Department of Periodontics, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Philadelphia, PA, 19104, USA.

M Odabas-Yigit (M)

Department of Periodontics, School of Dental Medicine, University of Pennsylvania, 240 South 40th Street, Philadelphia, PA, 19104, USA.

D F Kinane (DF)

Division of Periodontology, School of Dental Medicine, University of Geneva Faculty of Medicine, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH